La bourse ferme dans 7 h 41 min
  • CAC 40

    6 271,90
    -24,79 (-0,39 %)
     
  • Euro Stoxx 50

    4 011,59
    -8,32 (-0,21 %)
     
  • Dow Jones

    34 077,63
    -123,04 (-0,36 %)
     
  • EUR/USD

    1,2080
    +0,0039 (+0,33 %)
     
  • Gold future

    1 773,40
    +2,80 (+0,16 %)
     
  • BTC-EUR

    44 780,21
    -2 566,16 (-5,42 %)
     
  • CMC Crypto 200

    1 216,27
    -82,68 (-6,37 %)
     
  • Pétrole WTI

    64,04
    +0,66 (+1,04 %)
     
  • DAX

    15 369,81
    +1,42 (+0,01 %)
     
  • FTSE 100

    6 982,37
    -17,71 (-0,25 %)
     
  • Nasdaq

    13 914,77
    -137,58 (-0,98 %)
     
  • S&P 500

    4 163,26
    -22,21 (-0,53 %)
     
  • Nikkei 225

    29 100,38
    -584,99 (-1,97 %)
     
  • HANG SENG

    29 103,57
    -2,58 (-0,01 %)
     
  • GBP/USD

    1,3998
    +0,0014 (+0,10 %)
     

Global Synthetic Orthobiologics Market to Reach $1.1 Billion by 2027

ReportLinker
·25 min de lecture

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 8. - Influencer Pool: 1221. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.

New York, March 16, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Synthetic Orthobiologics Industry" - https://www.reportlinker.com/p06033067/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

  • Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.

  • Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.

  • Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.

  • Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.

  • Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.



Abstract:
- Global Synthetic Orthobiologics Market to Reach $1.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Synthetic Orthobiologics estimated at US$783.5 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 4.6% over the analysis period 2020-2027. Osteoarthritis & Degenerative Arthritis, one of the segments analyzed in the report, is projected to record a 4.8% CAGR and reach US$341.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Fracture Recovery segment is readjusted to a revised 4.8% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $211.5 Million, While China is Forecast to Grow at 7.5% CAGR
- The Synthetic Orthobiologics market in the U.S. is estimated at US$211.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$224.2 Million by the year 2027 trailing a CAGR of 7.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.
- Spinal Fusion Segment to Record 5.1% CAGR
- In the global Spinal Fusion segment, USA, Canada, Japan, China and Europe will drive the 4.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$118 Million in the year 2020 will reach a projected size of US$163.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$144.2 Million by the year 2027, while Latin America will expand at a 5.4% CAGR through the analysis period.

Select Competitors (Total 42 Featured) -

  • Anthrex

  • Bioventus LLC

  • Bone Biologics, Corp.

  • DePuy Synthes, Inc.

  • Genzyme

  • Globus Medical

  • Medtronic

  • NuVasive, Inc.

  • Orthofix, Inc.

  • Osiris Therapeutics, Inc.




Read the full report: https://www.reportlinker.com/p06033067/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Synthetic Orthobiologics Competitor Market Share Scenario
Worldwide (in %): 2020E
Global Competitor Market Shares by Segment

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Synthetic
Orthobiologics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Synthetic Orthobiologics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Synthetic Orthobiologics
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Osteoarthritis &
Degenerative Arthritis by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Osteoarthritis &
Degenerative Arthritis by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Osteoarthritis &
Degenerative Arthritis by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Fracture Recovery
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Fracture Recovery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Fracture Recovery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Spinal Fusion by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Spinal Fusion by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Spinal Fusion by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Soft Tissue
Injuries by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Soft Tissue Injuries by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Soft Tissue Injuries by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
Market Analytics
Table 19: USA Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 20: USA Historic Review for Synthetic Orthobiologics by
Application - Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 21: USA 15-Year Perspective for Synthetic Orthobiologics
by Application - Percentage Breakdown of Value Sales for
Osteoarthritis & Degenerative Arthritis, Fracture Recovery,
Spinal Fusion, Soft Tissue Injuries and Other Applications for
the Years 2012, 2020 & 2027

CANADA
Table 22: Canada Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 23: Canada Historic Review for Synthetic Orthobiologics
by Application - Osteoarthritis & Degenerative Arthritis,
Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 24: Canada 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

JAPAN
Table 25: Japan Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 26: Japan Historic Review for Synthetic Orthobiologics by
Application - Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 27: Japan 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

CHINA
Table 28: China Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 29: China Historic Review for Synthetic Orthobiologics by
Application - Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 30: China 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

EUROPE
Market Facts & Figures
Market Analytics
Table 31: Europe Current & Future Analysis for Synthetic
Orthobiologics by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 32: Europe Historic Review for Synthetic Orthobiologics
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 33: Europe 15-Year Perspective for Synthetic
Orthobiologics by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2020 & 2027

Table 34: Europe Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 35: Europe Historic Review for Synthetic Orthobiologics
by Application - Osteoarthritis & Degenerative Arthritis,
Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 36: Europe 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

FRANCE
Table 37: France Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 38: France Historic Review for Synthetic Orthobiologics
by Application - Osteoarthritis & Degenerative Arthritis,
Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 39: France 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

GERMANY
Table 40: Germany Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 41: Germany Historic Review for Synthetic Orthobiologics
by Application - Osteoarthritis & Degenerative Arthritis,
Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 42: Germany 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

ITALY
Table 43: Italy Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 44: Italy Historic Review for Synthetic Orthobiologics by
Application - Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 45: Italy 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 46: UK Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 47: UK Historic Review for Synthetic Orthobiologics by
Application - Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 48: UK 15-Year Perspective for Synthetic Orthobiologics
by Application - Percentage Breakdown of Value Sales for
Osteoarthritis & Degenerative Arthritis, Fracture Recovery,
Spinal Fusion, Soft Tissue Injuries and Other Applications for
the Years 2012, 2020 & 2027

SPAIN
Table 49: Spain Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 50: Spain Historic Review for Synthetic Orthobiologics by
Application - Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: Spain 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

RUSSIA
Table 52: Russia Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 53: Russia Historic Review for Synthetic Orthobiologics
by Application - Osteoarthritis & Degenerative Arthritis,
Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: Russia 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 55: Rest of Europe Current & Future Analysis for
Synthetic Orthobiologics by Application - Osteoarthritis &
Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft
Tissue Injuries and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 56: Rest of Europe Historic Review for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 57: Rest of Europe 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 58: Asia-Pacific Current & Future Analysis for Synthetic
Orthobiologics by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 59: Asia-Pacific Historic Review for Synthetic
Orthobiologics by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 60: Asia-Pacific 15-Year Perspective for Synthetic
Orthobiologics by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 61: Asia-Pacific Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 62: Asia-Pacific Historic Review for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 63: Asia-Pacific 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

AUSTRALIA
Table 64: Australia Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 65: Australia Historic Review for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 66: Australia 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

INDIA
Table 67: India Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 68: India Historic Review for Synthetic Orthobiologics by
Application - Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: India 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

SOUTH KOREA
Table 70: South Korea Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 71: South Korea Historic Review for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 72: South Korea 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

REST OF ASIA-PACIFIC
Table 73: Rest of Asia-Pacific Current & Future Analysis for
Synthetic Orthobiologics by Application - Osteoarthritis &
Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft
Tissue Injuries and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 74: Rest of Asia-Pacific Historic Review for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 75: Rest of Asia-Pacific 15-Year Perspective for
Synthetic Orthobiologics by Application - Percentage Breakdown
of Value Sales for Osteoarthritis & Degenerative Arthritis,
Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and
Other Applications for the Years 2012, 2020 & 2027

LATIN AMERICA
Table 76: Latin America Current & Future Analysis for Synthetic
Orthobiologics by Geographic Region - Argentina, Brazil, Mexico
and Rest of Latin America Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR

Table 77: Latin America Historic Review for Synthetic
Orthobiologics by Geographic Region - Argentina, Brazil, Mexico
and Rest of Latin America Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 78: Latin America 15-Year Perspective for Synthetic
Orthobiologics by Geographic Region - Percentage Breakdown of
Value Sales for Argentina, Brazil, Mexico and Rest of Latin
America Markets for Years 2012, 2020 & 2027

Table 79: Latin America Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 80: Latin America Historic Review for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 81: Latin America 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

ARGENTINA
Table 82: Argentina Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 83: Argentina Historic Review for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 84: Argentina 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

BRAZIL
Table 85: Brazil Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 86: Brazil Historic Review for Synthetic Orthobiologics
by Application - Osteoarthritis & Degenerative Arthritis,
Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 87: Brazil 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

MEXICO
Table 88: Mexico Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 89: Mexico Historic Review for Synthetic Orthobiologics
by Application - Osteoarthritis & Degenerative Arthritis,
Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 90: Mexico 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

REST OF LATIN AMERICA
Table 91: Rest of Latin America Current & Future Analysis for
Synthetic Orthobiologics by Application - Osteoarthritis &
Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft
Tissue Injuries and Other Applications - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 92: Rest of Latin America Historic Review for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 93: Rest of Latin America 15-Year Perspective for
Synthetic Orthobiologics by Application - Percentage Breakdown
of Value Sales for Osteoarthritis & Degenerative Arthritis,
Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and
Other Applications for the Years 2012, 2020 & 2027

MIDDLE EAST
Table 94: Middle East Current & Future Analysis for Synthetic
Orthobiologics by Geographic Region - Iran, Israel, Saudi
Arabia, UAE and Rest of Middle East Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 95: Middle East Historic Review for Synthetic
Orthobiologics by Geographic Region - Iran, Israel, Saudi
Arabia, UAE and Rest of Middle East Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 96: Middle East 15-Year Perspective for Synthetic
Orthobiologics by Geographic Region - Percentage Breakdown of
Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of
Middle East Markets for Years 2012, 2020 & 2027

Table 97: Middle East Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 98: Middle East Historic Review for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 99: Middle East 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

IRAN
Table 100: Iran Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 101: Iran Historic Review for Synthetic Orthobiologics by
Application - Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 102: Iran 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

ISRAEL
Table 103: Israel Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 104: Israel Historic Review for Synthetic Orthobiologics
by Application - Osteoarthritis & Degenerative Arthritis,
Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and
Other Applications Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 105: Israel 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

SAUDI ARABIA
Table 106: Saudi Arabia Current & Future Analysis for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 107: Saudi Arabia Historic Review for Synthetic
Orthobiologics by Application - Osteoarthritis & Degenerative
Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue
Injuries and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 108: Saudi Arabia 15-Year Perspective for Synthetic
Orthobiologics by Application - Percentage Breakdown of Value
Sales for Osteoarthritis & Degenerative Arthritis, Fracture
Recovery, Spinal Fusion, Soft Tissue Injuries and Other
Applications for the Years 2012, 2020 & 2027

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033067/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001